Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.“Despite being the ...

Key Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.

IT seems every week there’s a new claim about what fat jabs can cure – beyond banishing that belly. The so-called skinny jabs – that were initially designed as treatment for type ...

Tirzepatide 15 mg emerged as superior to other GLP-1 agonists for weight loss, for example, in a network meta-analysis of randomized controlled trials looking into obesity management.

Tirzepatide and semaglutide confer greater weight loss than other FDA-approved obesity medications with no significantly higher risk for adverse events, according to findings from a network meta ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.

Cardiology and GLP-1s: 10 things to know Advertisement. By: Francesca Mathewes. Thursday, June 26th, 2025. Print ... including the use of newly approved drugs, including GLP-1 receptor agonists like ...